Editorial: HIV prevention injection should be fast-tracked like COVID-19 vaccines

Editorial: HIV prevention injection should be fast-tracked like COVID-19 vaccines

Findings of two large phase III clinical trials first presented in 2020 showed a new HIV prevention injection to be highly effective. Yet, experts expect that the injection will only reach clinics in late 2022 or early 2023. If the rhetoric about bringing the urgency of COVID-19 to HIV is to mean anything, these timelines should be made shorter.

Read More

Analysis: SAHPRA decision on ivermectin shifts heavy responsibility to doctors

Analysis: SAHPRA decision on ivermectin shifts heavy responsibility to doctors

In allowing section 21 applications as part of a controlled compassionate access programme, SAHPRA has essentially shifted the responsibility for deciding whether the anti-parasitic ivermectin is safe and effective enough to be used in the treatment of COVID-19 to doctors. This places an enormous responsibility on doctors, writes Adele Baleta.

Read More